Efficacy and Safety of High- vs Low-Dose Sirolimus in Patients With Kaposiform Hemangioendothelioma: A Trial Protocol
Latest Information Update: 09 May 2024
At a glance
- Drugs Sirolimus (Primary)
- Indications Haemangioendothelioma
- Focus Therapeutic Use
Most Recent Events
- 21 Oct 2023 Status changed from recruiting to completed.
- 15 Jan 2023 Planned primary completion date changed from 20 Aug 2022 to 20 Aug 2023.
- 18 Apr 2022 New trial record